Raffles Medical Group
BSLHealthcareRaffles Medical Group Ltd provides private healthcare services in Singapore, Greater China, Vietnam, Cambodia, and Japan. It operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. The company operates Raffles Hospital that offers 24-hour acute and critical care; ambulance services and mobile medical calls to home, hotels, worksites, and onboard ships; and triage, emergency consultation, and inpatient ward admission services. Its hospital also provides various services, including covid 19 test, health screening, executive medical centre, statutory health check, dental, and chinese medicine; and specialist centers for cancer, children, counselling, diabetes and endocrine, dialysis, eye, fertility, heart, internal medicine, neuroscience, nuclear medicine, orthopaedic, pain management, rehabilitation, skin and aesthetics, surgery, urology, and woman, as well as ear, nose, and throat. In addition, the company offers health screening and clinical trial services; Raffles health eStore; and healthcare insurance to corporates and individuals. Further, it is involved in trading of pharmaceutical and nutraceutical products, and diagnostic equipment; operations of medical clinics and other general medical services; provision of management, consultancy, and third-party administration services; medical laboratory and imaging centre business; and investment property activities. The company was founded in 1976 and is based in Singapore.
Each figure shows where it came from. How we source our numbers →
Dividends
No upcoming ex-date announced yet.
2026 dividends: S$0.03 per security · indicative yield 3.51% at S$0.855 last.
Pays Annual · 5 years of dividends on record, from 2022 onwards.
Full dividend history
| Ex-Date | Amount / Security |
|---|---|
| 12 May 2026 | S$0.03 |
| 13 May 2025 | S$0.025 |
| 13 May 2024 | S$0.024 |
| 15 May 2023 | S$0.038 |
| 09 May 2022 | S$0.028 |
Dividends by year
| Year | Total / Security | Yield* |
|---|---|---|
| 2026 | S$0.03 | 3.51% |
| 2025 | S$0.025 | 2.92% |
| 2024 | S$0.024 | 2.81% |
| 2023 | S$0.038 | 4.44% |
| 2022 | S$0.028 | 3.27% |
*Yield uses the current last price (S$0.855) against each year's total — indicative only.
Earnings
No earnings data yet for this counter.
Announcements & news
- SGX page for BSL ↗Price, trading data and this counter's own announcements
- SGX company announcements ↗Every counter's filings, if you need to search across them
- Investor relations ↗Raffles Medical Group's own results and presentations
- Latest news ↗Press coverage and commentary
Added via FTSE ST All-Share expansion research (WebSearch-sourced ticker/name/sector only) -- fundamentals not yet researched.
Price synced from SGX. Other figures carry their own source and date above. How we source our numbers